Arca Biopharma | ABIO - Ativo Circulante





Ativo Circulante Alterar Data
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Amgen USD 34.96B 3.49B 2026-06
Arca Biopharma USD 884.56M 489.31M 2026-06
Biogen USD 7.31B 1.88B 2026-06
Brainstorm Cell Therapeutics USD 316K 132K 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Capricor Therapeutics USD 242.13M 40.96M 2026-06
Cipla INR 241.47B 7.71B 2026-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 137.28M 10.74M 2026-03
CSL USD 11.85B 1000K 2025-12
Cytokinetics USD 1.21B 369.02M 2026-06
Daiichi Sankyo JPY 2.23T 91.92B 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Grifols EUR 5.96B 316.31M 2025-12
Laboratory Of America USD 3.81B 743.9M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
Otsuka Holdings JPY 1.63T 30.58B 2026-06
Pfizer USD 41.36B 1.46B 2026-06
United Therapeutics USD 3.48B 611.7M 2026-06